Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Bartsch

Showing results (281-290 of 298) with videos related to

Pageof 30
Sort By:
Cancer Research and Treatment|December 9, 2014
CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot StudyIgor Tsaur, Anika Noack, Jasmina Makarevic, et al.
BJU International|June 21, 2005
Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancerAshutosh Tewari, Wolfgang Horninger, Ketan K Badani, et al.
Urology|February 25, 2003
Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysisLori J Sokoll, Daniel W Chan, Stephen D Mikolajczyk, et al.
Nature Biotechnology|January 9, 2007
Isolation of amniotic stem cell lines with potential for therapyPaolo De Coppi, Georg Bartsch, M Minhaj Siddiqui, et al.
Urology|October 18, 2002
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliterWolfgang Horninger, Carol D Cheli, Richard J Babaian, et al.
Urology|December 11, 2003
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancerYoshio Naya, Herbert A Fritsche, Carol D Cheli, et al.
Cancer Biomarkers : Section a of Disease Markers|June 16, 2012
Chemokines involved in tumor promotion and dissemination in patients with renal cell cancerIgor Tsaur, Anika Noack, Ana Maria Waaga-Gasser, et al.
Urology|October 18, 2002
Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?Yoshio Naya, Thomas A Stamey, Carol D Cheli, et al.
The Journal of Urology|October 9, 2003
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trialAlan W Partin, Michael K Brawer, Georg Bartsch, et al.
Journal of Translational Medicine|November 26, 2024
Urinary DNA-methylation and protein biomarkers identify urothelial carcinoma among other genitourinary diseases and cancer-free individualsKerstin Lang, Christina U Köhler, Katharina Wichert, et al.
Pageof 30

Showing results (281-290 of 298) with videos related to

Sort By:
Pageof 30
Cancer Research and Treatment|December 9, 2014
CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot StudyIgor Tsaur, Anika Noack, Jasmina Makarevic, et al.
BJU International|June 21, 2005
Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancerAshutosh Tewari, Wolfgang Horninger, Ketan K Badani, et al.
Urology|February 25, 2003
Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysisLori J Sokoll, Daniel W Chan, Stephen D Mikolajczyk, et al.
Nature Biotechnology|January 9, 2007
Isolation of amniotic stem cell lines with potential for therapyPaolo De Coppi, Georg Bartsch, M Minhaj Siddiqui, et al.
Urology|October 18, 2002
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliterWolfgang Horninger, Carol D Cheli, Richard J Babaian, et al.
Urology|December 11, 2003
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancerYoshio Naya, Herbert A Fritsche, Carol D Cheli, et al.
Cancer Biomarkers : Section a of Disease Markers|June 16, 2012
Chemokines involved in tumor promotion and dissemination in patients with renal cell cancerIgor Tsaur, Anika Noack, Ana Maria Waaga-Gasser, et al.
Urology|October 18, 2002
Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?Yoshio Naya, Thomas A Stamey, Carol D Cheli, et al.
The Journal of Urology|October 9, 2003
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trialAlan W Partin, Michael K Brawer, Georg Bartsch, et al.
Journal of Translational Medicine|November 26, 2024
Urinary DNA-methylation and protein biomarkers identify urothelial carcinoma among other genitourinary diseases and cancer-free individualsKerstin Lang, Christina U Köhler, Katharina Wichert, et al.
Pageof 30